126
Participants
Start Date
December 7, 2015
Primary Completion Date
December 9, 2016
Study Completion Date
December 9, 2016
Oseltamivir
75 mg capsules orally BID from Day 1 to Day 5.
MEDI8852
MEDI8852 is a human IgG1 kappa monoclonal antibody (mAb) administered as a single IV infusion of 750 mg or 3000 mg on Day 1.
Placebo
Placebo is salt-water solution containing no active ingredients and administered as a single IV infusion on Day 1.
Research Site, Johannesburg
Research Site, Durban
Research Site, Winnie Mandela
Research Site, Welkom
Research Site, Smithfield
Research Site, Shelby
Research Site, Hickory
Research Site, Hialeah
Research Site, Hialeah
Research Site, Miami Lakes
Research Site, Hialeah
Research Site, North Miami Beach
Research Site, Miami
Research Site, Miami
Research Site, Miami
Research Site, Avon
Research Site, Muncie
Research Site, Troy
Research Site, Butte
Research Site, New Orleans
Research Site, San Antonio
Research Site, Clinton
Research Site, Los Angeles
Research Site, Long Beach
Research Site, Canoga Park
Research Site, Upland
Research Site, Pretoria
Research Site, Pretoria
Research Site, Pretoria
Research Site, Pretoria
Research Site, Thabazimbi
Lead Sponsor
MedImmune LLC
INDUSTRY